All In Biotech

Drug Trial Radar · NCT05695950

A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered GLPG3667 Once Daily for 24 Weeks in Adult Subjects With Dermatomyositis

Last checked: Nov 19, 2026Latest source record: May 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Feb 27, 2023

Primary completion

Oct 13, 2025

Study completion Apr 20, 2026

Sponsor

Lead sponsor
Lakefront Biotherapeutics NVIndustry
Sponsor type
Industry
First posted
Jan 25, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of orally administered GLPG3667 once daily for 24 weeks in adult participants with dermatomyositis (DM), followed by an open-label extension (OLE) period until Week 48.

Conditions

  • Dermatomyositis

Interventions

  • GLPG3667Drug

    GLPG3667 capsules will be administered per dose and schedule specified in the arm description.

  • PlaceboDrug

    Placebo matching to GLPG3667 capsules will be administered per schedule specified in the arm description.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total improvement score [TIS] according to the American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) criteriaTime frame: Week 24

Locations

54 sites in 15 countries. Site status is shown where the registry gives one.

  • HonorHealth Neurology

    Scottsdale, Arizona

  • Inland Rheumatology Clinical Trials, Inc.

    Upland, California

  • New Access Research and Medical Center

    Kendall, Florida

  • Omega Research Orlando, LLC

    Orlando, Florida

  • Augusta University

    Augusta, Georgia

  • St. Paul Rheumatology

    Eagan, Minnesota

  • Northwell Health, LLC PRIME

    Lake Success, New York

  • Altoona Center for Clinical Research, P.C.

    Duncansville, Pennsylvania

  • Fundacion Respirar Consultorios Médicos Dr. Doreski

    Buenos Aires, Argentina

  • Hospital Cordoba

    Córdoba, Argentina

  • Hospital Italiano de La Plata

    La Plata, Argentina

  • Framingham Centro Medico

    La Plata, Argentina

  • Instituto Medico CER

    Quilmes, Argentina

  • UZ Leuven

    Leuven, Belgium

  • Enroll SpA

    Santiago, Chile

  • BioMedica Research Group Psicomedica Clinical and Research Group

    Santiago, Chile

  • Clinica de la Costa S.A.S

    Barranquilla, Colombia

  • Centro de Investigacion Medico Asistencial S.A.S

    Barranquilla, Colombia

  • Healthy Medical Center

    Zipaquirá, Colombia

  • Polyclinic Bonifarm

    Zagreb, Croatia

  • Solmed Polyclinic

    Zagreb, Croatia

  • Revmatologicky Ustav

    Prague, Czechia

  • CHU de Nice Hôpital Pasteur 2 Centre de Réf des Maladies Neuromusculaires et SLA

    Nice, France

  • Groupe Hospitalier Pitie-Salpetriere service de médecine interne et immunologie cliniqu

    Paris, France

  • CHU Strasbourg - Hôpital Hautepierre service de rhumatologie

    Strasbourg, France

  • Charité - Campus Charité Mitte - Klinik für Dermatologie, Venerologie und Allergologie

    Berlin, Germany

  • Helios Fachklinik Vogelsang-Gommern

    Gommern, Germany

  • Universitätsklinikum Tübingen - Universitäts-Hautklinik

    Tübingen, Germany

  • Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili) Medicina Interna

    Brescia, Italy

  • Azienda Ospedaliero Universitaria Policlinico. PO San Marco

    Catania, Italy

  • Ospedale San Raffaele U.O. di Medicina Gen. Ind. Immunologico-Clinica

    Milan, Italy

  • Azienda Ospedaliero Universitaria Pisana U.O. Reumatologia Universitaria

    Pisa, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Roma, Italy

  • Istituto Clinico Humanitas U.O. Reumatologia

    Rozzano, Italy

  • Ospedale San Giovanni Bosco

    Torino, Italy

  • Medical Care & Research SA de CV

    Mérida, Mexico

  • Centro de Investigacion Clínica GRAMEL S.C

    México, Mexico

  • Consultorio de Reumatologia Hospital Angeles Lindavista

    México, Mexico

  • Centro de Alta Especialidad en Reumatología e Investigación del Potosí S.C.

    San Luis Potosí City, Mexico

  • Nova Reuma Domysławska i Rusiłowicz, Spółka Partnerska Lekarza Reumatologa i Fizjoterapeuty

    Bialystok, Poland

Showing 40 of 54 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.